Koers Vivimed Labs Ltd NSE India S.E.
Aandelen
INE526G01013
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
26/02 | Vivimed Labs CFO neemt ontslag | MT |
14/02 | Vivimed Labs Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 | CI |
Omzet 2022 | 2,39 mld. 28,59 mln. 26,57 mln. | Omzet 2023 | 1,88 mld. 22,54 mln. 20,95 mln. | Marktkapitalisatie | 547 mln. 6,56 mln. 6,09 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -677 mln. -8,11 mln. -7,54 mln. | Nettowinst (verlies) 2023 | -3,28 mld. -39,37 mln. -36,59 mln. | EV/omzet 2022 | 1,98 x |
Nettoschuld 2022 | 3,52 mld. 42,15 mln. 39,17 mln. | Nettoschuld 2023 | 3,77 mld. 45,22 mln. 42,02 mln. | EV/omzet 2023 | 2,3 x |
K/w-verhouding 2022 |
-1,78
x | K/w-verhouding 2023 |
-0,17
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 74,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 09-11-89 |
Compliance Officer | - | - | |
S. G. Saurabh
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 09-11-89 |
Sandeep Varalwar
BRD | Director/Board Member | 55 | 23-01-08 |
Subhash Varalwar
BRD | Director/Board Member | 76 | 09-11-89 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. |